Prakash, S <br/><br/>
Artificial cells microencapsulated genetically engineered E. coli DH5 cells for the lowering of plasma creatinine in-vitro and in-vivo.  [electronic resource] 

 -  Artificial cells, blood substitutes, and immobilization biotechnology  Sep 2000 
 - 397-408 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1073-1199 
<br/><br/><label>Standard No.: </label>10.3109/10731190009118584  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Creatinine--blood<br/>Disease Models, Animal<br/>Drug Compounding--methods<br/>Escherichia coli--genetics<br/>Genetic Engineering<br/>Male<br/>Membranes, Artificial<br/>Rats<br/>Rats, Wistar<br/>Time Factors<br/>Uremia--therapy